Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/28/2023* 16:30 EST Earnings Call Q4 2022 -- -- --
02/28/2023* -- Results Q4 2022 -- -1.17 --
11/08/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/08/2022 -- Results Q3 2022 -2.15 1.59 -235.0%
08/08/2022 16:30 EST Earnings Call Q2 2022 -- -- --
08/08/2022 -- Results Q2 2022 -6.53 5.18 -226.0%
05/09/2022 16:30 EST Earnings Call Q1 2022 -- -- --
05/09/2022 -- Results Q1 2022 2.56 2.49 2.73%
*Estimated Date/Time

Earnings

Next Report Date 02/28/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/08/2022
Beat/Miss Upgrade
Return Since -15.93%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
URL https://www.novavax.com
Investor Relations URL https://ir.novavax.com/
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2023 (est.)
Last Earnings Release Nov. 08, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
41.48%
-84.98%
-1.59%
48.39%
-89.18%
2.70K%
28.30%
-88.45%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
--
--
--
--
28.09%
434.1%
143.1%
-28.20%
7.30%
4.68%
16.13%
25.06%
-6.73%
3.51%
66.74%
-11.00%
1.16%
15.32%
24.40%
-5.14%
16.21%
10.85%
11.45%
7.31%
25.37%
-10.37%
17.83%
40.45%
16.15%
31.06%
66.08%
37.51%
As of December 02, 2022.

Profile

Edit
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
URL https://www.novavax.com
Investor Relations URL https://ir.novavax.com/
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2023 (est.)
Last Earnings Release Nov. 08, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TINY 126845.0 USD 5.07%
BDOP.TO 1.688M USD 4.47%
MRND 70890.00 USD 1.70%
XDNA.TO 83883.00 USD 1.69%
GERM 384068.0 USD 1.58%
IDNA 2.752M USD 1.56%
F0000173CC 48160.00 USD 0.48%
FWYARX 43000.00 USD 0.43%
F00001CIVX 32832.00 USD 0.33%
F000016JRT 27224.00 USD 0.27%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter NVAX Tweets